Chronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN study
Deniz Hastan(University of Amsterdam), Peter Burney(Imperial College London), Torsten Zuberbier(Charité - Universitätsmedizin Berlin), R B Newson(Imperial College London), Jovanka Karadzinska Bislimovska(Ss. Cyril and Methodius University in Skopje), Cornelis M. van Drunen(University of Amsterdam), Philippe‐Jean Bousquet(Institut National du Cancer), Angelina Bockelbrink(Charité - Universitätsmedizin Berlin), Deborah Jarvis(Kingston Technology (United States)), Bibi Lange(Odense University Hospital), Łukasz Kasper(Jagiellonian University), Bo Lundbäck(University of Gothenburg), Bertil Forsberg(Umeå University), Maria Gunnbjörnsdóttir(Uppsala University), Peter Tomassen(Ghent University), C. Bachert(Ghent University), Jean Bousquet(Humboldt-Universität zu Berlin), Grzegorz Brożek(Medical University of Silesia), Andreina Bruno(Istituto di Biomedicina e di Immunologia Molecolare Alberto Monroy), E. Salagean(University of Southampton), Е. Тоскала(Children's Hospital of Philadelphia), M. L. Kowalski(Medical University of Lodz), W. J. Fokkens(University of Amsterdam), Ana Todo‐Bom, S. E. Dahlén(Karolinska Institutet), Ursula Krämer(Leibniz Institute of Environmental Medicine)
Cited by 1,114
Related Papers
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
|The Lancet|2007|2.4k
The European Community Respiratory Health Survey
|European Respiratory Journal|1994|2k
Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)
|The Lancet Oncology|2013|1.6k